UroGen Pharma Income Statement (2016-2025) | URGN

1Y3Y5Y7Y10YAll
Download Data
Income Statement Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.02M7.81M0.33M0.48M0.36M0.28M0.02M0.37M3.46M7.97M7.49M13.03M11.35M16.17M13.56M16.60M16.10M18.09M17.19M21.14M20.85M23.53M18.78M21.85M25.20M24.57M20.25M24.21M27.48M
Cost of Revenue 0.02M0.29M0.29M0.43M0.32M1.05M0.05M0.31M0.65M0.90M1.43M1.24M1.59M1.52M1.85M2.02M2.26M2.27M2.44M2.37M2.29M1.73M2.23M2.45M2.47M2.33M3.55M3.28M
Gross Profit 1,000.00M7.52M0.04M0.05M0.05M-0.77M0.02M0.32M3.15M7.31M6.59M11.61M10.11M14.59M12.04M14.76M14.08M15.83M14.93M18.70M18.48M21.24M17.05M19.62M22.75M22.09M17.92M20.66M24.20M
Operating items
Research & Development 2.35M2.87M2.37M2.66M3.65M5.62M6.76M7.62M8.27M9.57M11.46M9.73M10.00M9.48M20.09M8.11M10.21M12.40M10.51M12.12M11.92M13.08M12.70M12.64M13.09M14.48M12.50M11.58M10.23M11.30M15.49M15.40M11.36M14.89M19.87M18.91M14.01M
Selling, General & Administrative 1.04M3.24M1.23M0.88M2.30M2.20M3.44M6.07M10.21M10.74M12.55M12.71M13.78M13.97M19.75M24.02M22.07M22.16M22.19M22.30M21.62M21.42M21.30M20.83M19.07M21.63M24.47M22.49M21.75M24.55M27.30M30.06M28.94M34.86M34.97M43.20M37.58M
Operating Expenses 3.40M6.11M3.60M3.54M5.95M7.82M10.20M13.69M18.48M20.32M24.02M22.43M23.77M23.45M39.84M32.12M32.28M34.57M32.70M34.43M33.55M34.50M34.00M33.47M32.16M36.11M36.97M34.08M31.98M35.85M42.79M45.46M40.30M49.75M54.84M62.11M51.59M
Operating Income 3.40M6.11M13.90M-3.54M5.95M-0.30M-10.16M-13.64M-18.43M-21.09M-24.02M-22.43M-23.75M-23.45M-39.84M-31.80M-29.12M-27.25M-26.11M-22.82M-23.44M-19.91M-21.96M-18.71M-18.09M-20.28M-22.05M-15.38M-13.50M-14.61M-25.74M-25.84M-17.55M-27.66M-36.91M-41.45M-27.39M
EBIT 3.40M6.11M13.90M-3.54M5.95M-0.30M-10.16M-13.64M-18.43M-21.09M-24.02M-22.43M-23.75M-23.45M-39.84M-31.80M-29.12M-27.25M-26.11M-22.82M-23.44M-19.91M-21.96M-18.71M-18.09M-20.28M-22.05M-15.38M-13.50M-14.61M-25.74M-25.84M-17.55M-27.66M-36.91M-41.45M-27.39M
Non-operating items
Interest & Investment Income -0.12M-0.36M0.45M0.31M0.27M0.03M0.06M0.02M0.00M0.13M0.48M0.41M0.63M0.41M0.91M1.54M1.61M1.71M2.60M2.75M2.11M1.30M0.98M
Other Non Operating Income -0.00M-0.00M0.01M0.00M-0.12M
Non Operating Income -0.08M1.88M-4.50M0.25M-0.01M-0.11M0.26M0.99M0.18M-0.24M-0.02M-0.08M-0.00M0.10M0.04M-0.40M-0.01M-0.03M0.07M-0.71M
Net income details
EBT 3.40M6.11M12.92M-3.66M5.70M-0.30M-10.07M-14.00M-18.03M-20.53M-24.02M-22.43M-23.75M-23.45M-39.84M-31.35M-28.82M-27.15M-25.93M-25.91M-30.21M-27.32M-28.07M-26.66M-25.12M-28.18M-30.19M-24.08M-21.89M-22.16M-32.23M-33.37M-23.58M-34.86M-43.45M-48.92M-34.40M
Tax Provisions 3.37M0.31M1.14M0.33M0.03M0.71M0.69M0.02M0.05M-0.01M3.85M0.05M0.04M0.09M2.65M0.39M1.01M-1.05M
Profit After Tax 3.32M7.99M12.92M3.42M6.20M-0.30M-10.09M-13.38M-18.03M-20.53M-23.72M-21.44M-22.48M-22.25M-38.97M-31.35M-28.82M-30.53M-25.93M-26.22M-30.21M-28.45M-28.39M-26.69M-25.83M-28.87M-30.21M-24.14M-21.88M-26.02M-32.29M-33.40M-23.67M-37.51M-43.84M-49.94M-33.35M
Income from Continuing Operations 3.40M6.11M12.92M-3.66M5.70M-0.30M-10.07M-14.00M-18.03M-20.53M-24.02M-22.43M-23.75M-23.45M-39.84M-31.35M-28.82M-30.53M-25.93M-26.22M-30.21M-28.45M-28.39M-26.69M-25.83M-28.87M-30.21M-24.14M-21.88M-26.02M-32.29M-33.40M-23.67M-37.51M-43.84M-49.94M-33.35M
Consolidated Net Income 3.40M6.11M12.92M-3.66M5.70M-0.30M-10.07M-14.00M-18.03M-20.53M-24.02M-22.43M-23.75M-23.45M-39.84M-31.35M-28.82M-30.53M-25.93M-26.22M-30.21M-28.45M-28.39M-26.69M-25.83M-28.87M-30.21M-24.14M-21.88M-26.02M-32.29M-33.40M-23.67M-37.51M-43.84M-49.94M-33.35M
Income towards Parent Company 3.40M6.11M12.92M-3.66M5.70M-0.30M-10.07M-14.00M-18.03M-20.53M-24.02M-22.43M-23.75M-23.45M-39.84M-31.35M-28.82M-30.53M-25.93M-26.22M-30.21M-28.45M-28.39M-26.69M-25.83M-28.87M-30.21M-24.14M-21.88M-26.02M-32.29M-33.40M-23.67M-37.51M-43.84M-49.94M-33.35M
Net Income towards Common Stockholders 3.40M6.11M12.92M-3.66M5.70M-0.30M-10.07M-14.00M-18.03M-20.53M-24.02M-22.43M-23.75M-23.45M-39.84M-31.35M-28.82M-30.53M-25.93M-26.22M-30.21M-28.45M-28.39M-26.69M-25.83M-28.87M-30.21M-24.14M-21.88M-26.02M-32.29M-33.40M-23.67M-37.51M-43.84M-49.94M-33.35M
Additional items
EPS (Basic) 1.703.735.61-1.740.70-0.02-1.04-0.88-1.14-1.28-1.46-1.16-1.08-1.06-1.94-1.44-1.31-1.38-1.17-1.17-1.35-1.27-1.25-1.18-1.13-1.25-1.30-1.03-0.68-0.72-0.87-0.82-0.51-0.80-0.92-1.05-0.69
EPS (Weighted Average and Diluted) 1.56-0.74
Shares Outstanding (Weighted Average) 2.31M2.31M9.20M13.05M9.72M15.27M15.78M16.09M15.75M19.34M20.83M20.92M20.53M21.16M21.75M22.06M21.78M22.24M22.33M22.38M22.35M22.63M22.70M22.80M22.81M23.28M23.46M32.30M36.15M37.06M40.50M46.78M47.03M47.42M47.74M48.06M
Shares Outstanding (Diluted Average) 8.29M13.61M
EBITDA 3.40M6.11M13.90M-3.54M5.95M-0.30M-10.16M-13.64M-18.03M-20.53M-23.72M-22.43M-22.20M-22.23M-39.00M-30.90M-29.08M-30.75M-26.06M-26.32M-30.25M-28.48M-28.44M-26.68M-25.93M-28.82M-30.15M-24.25M-21.86M-25.87M-32.34M-33.40M-23.41M-37.69M-43.88M-49.95M-33.33M
Interest Expenses 0.25M-0.01M-0.41M-0.56M
Tax Rate -12.43%-1.20%-4.16%-1.16%-0.12%-2.82%-2.44%-0.07%-0.22%0.04%-17.39%-0.17%-0.11%-0.39%-7.60%-0.90%-2.07%3.06%